February 18, 2021 -- Bioanalytical testing firm Eurofins Scientific has purchased Beacon Discovery, a contract research organization focused on G-protein coupled receptor (GPCR) research.
Beacon has a large portfolio of validated in vitro pharmacology, "absorption, distribution, metabolism, and excretion" (collectively known as ADMET), and chemistry services for integrated drug discovery clients. The deal is expected to close in coming weeks, according to Eurofins.
The acquisition will support Eurofins' efforts to boost its drug discovery and new therapeutics offerings, it said.
Financial details of the acquisition were not disclosed.